中山大学孙逸仙纪念医院基础与转化医学研究中心//广东省恶性肿瘤表观遗传与基因调控重点实验室, 广东 广州510080
李文佳,硕士生,研究方向:恶性肿瘤表观遗传与基因调控研究,E-mail:liwj229@mail.sysu.edu.cn
收稿:2021-12-21,
纸质出版:2022-03-20
移动端阅览
李文佳,朱元昕,胡开顺.MMS21通过维持MCM2-7复合物稳定性促进肝细胞癌增殖活性[J].中山大学学报(医学科学版),2022,43(02):203-211.
LI Wen-jia,ZHU Yuan-xin,HU Kai-shun.MMS21 Maintains the Stability of Complex MCM2-7 to Promote Hepatocellular Carcinoma Proliferation[J].Journal of Sun Yat-sen University(Medical Sciences),2022,43(02):203-211.
李文佳,朱元昕,胡开顺.MMS21通过维持MCM2-7复合物稳定性促进肝细胞癌增殖活性[J].中山大学学报(医学科学版),2022,43(02):203-211. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2022.0205.
LI Wen-jia,ZHU Yuan-xin,HU Kai-shun.MMS21 Maintains the Stability of Complex MCM2-7 to Promote Hepatocellular Carcinoma Proliferation[J].Journal of Sun Yat-sen University(Medical Sciences),2022,43(02):203-211. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2022.0205.
目的
2
探讨SUMO E3泛素连接酶MMS21在肝细胞癌的表达及发挥作用机制。
方法
2
利用GEPIA2和CPATC数据库分析MMS21在肝细胞癌中的mRNA和蛋白表达变化及与患者预后的关系;设计两条siRNA分别敲低肝癌细胞内源性MMS21的表达,并采用流式细胞技术检测细胞周期分布比例;进行BrdU染色和DNA fiber实验检测细胞增殖能力与DNA合成速度;构建带有MYC标签的MMS21蛋白过表达载体,并在细胞系SK-hep1中建立其稳定表达的细胞株;利用Co-IP联合质谱分析的方法鉴定MMS21的互作蛋白组并进行信号通路富集分析;采用Western Blot,检测MMS21对细胞周期相关蛋白的影响。
结果
2
在肝细胞癌中,与癌旁组织(160例)相比,MMS21在癌组织(369例)中显著高表达(
P
<
0.05),其高表达与患者不良预后相关(
P
<
0.01)。在肝癌细胞系中,使用两条siRNA分别敲低内源MMS21的表达后,SK-hep1细胞中G1期的细胞比例显著上升(
P
<
0.001;
P
<
0.01),S期比例显著下降(
P
<
0.01;
P
<
0.05),G2/M期比例下降(
P
<
0.05;
P
<
0.05);HepG2细胞中G1期的细胞比例显著上升(
P
<
0.001;
P
<
0.001),S期比例显著下降(
P
<
0.01;
P
<
0.01),G2/M期比例下降(
P
<
0.05;
P
<
0.05);SK-hep1细胞的DNA合成速度明显减慢(
P
<
0.0001;
P
<
0.0001);SK-hep1和HepG2细胞增殖能力显著下降(
P
<
0.01;
P
<
0.001;
P
<
0.001;
P
<
0.001)。质谱鉴定MMS21的互作蛋白组,共鉴定到641个高可信度蛋白;通路富集分析表明,这些结合蛋白显著富集于细胞周期相关的生理过程;进一步的Western Blot结果表明:MMS21的缺失能抑制S期和G2/M期的周期蛋白表达量,降低微小染色体维持蛋白家族(MCMs)的蛋白水平。
结论
2
SUMO E3连接酶MMS21在肝细胞癌中高表达,并与患者不良预后相关;MMS21与肝癌细胞的增殖密切相关,能够维持细胞周期蛋白和复制复合物MCM蛋白稳定性,促进肝癌细胞的增殖能力。
Objective
2
To investigate the expression level of MMS21 and its functions in hepatocellular carcinoma.
Methods
2
The GEPIA2 and CPATC databases were used to analyze the mRNA and protein levels of MMS21 in adjacent and carcinoma tissues; the endogenous expression levels of MMS21 were reduced individually by two siRNAs. Meanwhile, flow cytometry was used to detect the distribution ratio of cell cycle of hepatocellular carcinoma cells. BrdU staining and DNA fiber assay were employed to determine cells proliferation rate, and colony assay was used to evaluate the ability of cell proliferation; the MYC tagged MMS21 was cloned and transfected into SK-hep1 to generate MMS21 stably overexpressed cells. Co-IP combined with mass spectrometry were used to identify MMS21-interacting proteome and map interactive pathway; Western Blot (WB) was performed to determine the effect of MMS21 towards cell cycle-related proteins.
Results
2
Compared with adjacent tissues (
n
= 160 ), MMS21 was significantly higher expressed in cancerous tissues (
n
= 369;
P
<
0.05) and its high expression was associated with poor prognosis (
P
<
0.01 ) in hepatocellular carcinoma; Knockdown of endogenous MMS21 by two siRNAs led to the increase of the proportion of cells in G0/G1 phase (
P
<
0.001;
P
<
0.01), and the decrease of the ratio of cells in S (
P
<
0.01;
P
<
0.05), G2/M (
P
<
0.05;
P
<
0.05) phase. Moreover, depletion of endogenous MMS21 greatly attenuated the speed of DNA replication (
P
<
0.000 1;
P
<
0.000 1) and the rate of cell proliferation (
P
<
0.01;
P
<
0.001). Mass spectrometry analysis identified the total of 641 high-confidence proteins for MMS21, and interactive pathway analysis showed that these binding proteins were highly correlated with cell cycle-related genes. The results of Western Blot further confirmed this conclusion, and depletion of endogenous MMS21 markedly reduced the protein levels of Microchromosome maintenance protein family (MCMs).
Conclusions
2
MMS21 is highly expressed in hepatocellular carcinoma and positively correlated with the poor prognosis. MMS21 is closely related to the proliferation of Hepatocellular Carcinoma and regulated the stability of cell cycle related proteins and MCM family.
Sung H , Ferlay J , Siegel RL , et al . Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin , 2021 , 71 ( 3 ): 209 - 249 .
Zhao X , Blobel G . A SUMO ligase is part of a nuclear multiprotein complex that affects DNA repair and chromosomal organization [J]. Proc Natl Acad Sci U S A , 2005 , 102 ( 13 ): 4777 - 4782 .
Dungrawala H , Rose KL , Bhat KP , et al . The replication checkpoint prevents two types of fork collapse without regulating replisome stability [J]. Mol Cell , 2015 , 59 ( 6 ): 998 - 1010 .
Branzei D , Sollier J , Liberi G , et al . Ubc9- and mms21-mediated sumoylation counteracts recombinogenic events at damaged replication forks [J]. Cell , 2006 , 127 ( 3 ): 509 - 522 .
Zhang J , Augustine RC , Suzuki M , et al . The SUMO ligase MMS21 profoundly influences maize development through its impact on genome activity and stability [J]. PLoS Genet , 2021 , 17 ( 10 ): e1009830 .
Pond KW , de Renty C , Yagle MK , et al . Rescue of collapsed replication forks is dependent on NSMCE2 to prevent mitotic DNA damage [J]. PLoS Genet , 2019 , 15 ( 2 ): e1007942 .
Hu K , Wu W , Li Y , et al . Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents [J]. EMBO Rep , 2019 , 20 ( 5 ): e46166 .
Torimura T , Iwamoto H . Treatment and the prognosis of hepatocellular carcinoma in Asia [J]. Liver Int , 2021 , doi: 10.1111/liv.15130 http://dx.doi.org/10.1111/liv.15130 .
Jing L , Bo W , Yourong F , et al . Sema4C mediates EMT inducing chemotherapeutic resistance of miR-31-3p in cervical cancer cells [J]. Sci Rep , 2019 , 9 ( 1 ): 17727 .
Jacome A , Gutierrez-Martinez P , Schiavoni F , et al . NSMCE2 suppresses cancer and aging in mice independently of its SUMO ligase activity [J]. EMBO J , 2015 , 34 ( 21 ): 2604 - 2619 .
Potts PR , Yu H . The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins [J]. Nat Struct Mol Biol , 2007 , 14 ( 7 ): 581 - 590 .
Ni HJ , Chang YN , Kao PH , et al . Depletion of SUMO ligase hMMS21 impairs G1 to S transition in MCF-7 breast cancer cells [J]. Biochim Biophys Acta , 2012 , 1820 ( 12 ): 1893 - 1900 .
Potts PR . The Yin and Yang of the MMS21-SMC5/6 SUMO ligase complex in homologous recombination [J]. DNA Repair (Amst) , 2009 , 8 ( 4 ): 499 - 506 .
Halliwell JA , Gravells P , Bryant HE . DNA Fiber Assay for the analysis of DNA replication progression in human pluripotent stem cells [J]. Protoc Stem Cell Biol , 2020 , 54 ( 1 ): e115 .
Duan X , Sarangi P , Liu X , et al . Structural and functional insights into the roles of the Mms21 subunit of the Smc5/6 complex [J]. Mol Cell , 2009 , 35 ( 5 ): 657 - 668 .
Forsburg SL . Eukaryotic MCM proteins: beyond replication initiation [J]. Microbiology and molecular biology reviews : Microbiol Mol Biol Rev , 2004 , 68 ( 1 ): 109 - 131 .
Hayashi-Takanaka Y , Hayashi Y , Hirano Y , et al . Chromatin loading of MCM hexamers is associated with di-/tri-methylation of histone H4K20 toward S phase entry [J]. Nucleic Acids Res , 2021 , 49 ( 21 ): 12152 - 12166 .
Pasion SG , Forsburg SL . Nuclear localization of Schizosaccharomyces pombe Mcm2/Cdc19p requires MCM complex assembly [J]. Mol Biol Cell , 1999 , 10 ( 12 ): 4043 - 4057 .
Lee PH , Osley MA . Who gets a license: DNA synthesis in quiescent cells re-entering the cell cycle [J]. Curr Genet , 2021 , 67 ( 4 ): 539 - 543 .
Jenkyn-Bedford M , Jones ML , Baris Y , et al . A conserved mechanism for regulating replisome disassembly in eukaryotes [J]. Nature , 2021 , 600 ( 7890 ): 743 - 747 .
Wang Y , Chen H , Zhang J , et al . MCM family in gastrointestinal cancer and other malignancies: From functional characterization to clinical implication [J]. Biochim Biophys Acta Rev Cancer , 2020 , 1874 ( 2 ): 188415 .
0
浏览量
313
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621
